Sakoda Jon
SEC-identified person · CIK 1589961 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aveo Pharmaceuticals, INC. AVEO | Officer | filed 2016 - 2018 |
| Ardelyx, INC. ARDX | Officer | filed 2015 - 2018 |
| Oncothyreon Inc. ONTY | Officer | filed 2017 - 2018 |
| Oruka Therapeutics, Inc. ORKA | Officer | filed 2015 - 2018 |
| Genocea Biosciences, INC. GNCA | Officer | filed 2018 - 2018 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017 - 2017 |
| Regulus Therapeutics Inc. RGLS | Officer | filed 2017 - 2017 |
| Achaogen, Inc. AKAO | Officer | filed 2016 - 2016 |
| Opower, INC. OPWR | Director | filed 2014 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.